Jaguar Health, Inc.(JAGX)
Pharmaceuticals
Specialty Pharma
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-04-02 | MICEK JOHN Director | Purchase | +18,000 | +28.71%80,701 | $25000.00 | $450,000,000 | View SEC filing | |
| 2025-04-02 | King Steven R. See Remarks | Purchase | +7,200 | +100.00%7,200 | $10000.00 | $72,000,000 | View SEC filing | |
| 2025-04-02 | Siegel Jonathan B. Director | Purchase | +18,000 | +34.66%69,933 | $25000.00 | $450,000,000 | View SEC filing | |
| 2025-04-02 | CONTE LISA A CEO and President | Purchase | +18,000 | +100.00%18,000 | $25000.00 | $450,000,000 | View SEC filing | |
| 2025-04-02 | Chaturvedi Pravin R Chief Scientific Officer | Purchase | +7,200 | +100.00%7,200 | $10000.00 | $72,000,000 | View SEC filing | |
| 2025-04-02 | BOCHNOWSKI JAMES J Director | Purchase | +54,004 | +217.13%78,876 | $75000.00 | $4,050,300,000 | View SEC filing | |
| 2025-04-02 | Wolin Jonathan S. See Remarks | Purchase | +18,000 | +100.00%18,000 | $25000.00 | $450,000,000 | View SEC filing | |
| 2025-04-02 | Lizak Carol R. Chief Financial Officer | Purchase | +10,800 | +100.00%10,800 | $15000.00 | $162,000,000 | View SEC filing | |
| 2023-01-03 | Wolin Jonathan S. Chief of Staff, CCO & GC | Purchase | +317 | +4.76%6,983 | $0.03 | $10 | View SEC filing | |
| 2022-03-30 | Lizak Carol R. Chief Financial Officer | Purchase | +7,968 | +100.00%7,968 | $2.51 | $20,000 | View SEC filing | |
| 2022-03-30 | CONTE LISA A CEO and President | Purchase | +7,968 | +22765.71%8,003 | $2.51 | $20,000 | View SEC filing | |
| 2021-06-07 | BOCHNOWSKI JAMES J Director | Sale | -444 | -0.05%954,390 | $1.75 | $775 | View SEC filing | |
| 2019-07-25 | Siegel Jonathan B. Director | Purchase | +72,490 | +12695.27%73,061 | $0.35 | $25,410 | View SEC filing | |
| 2019-07-25 | BOCHNOWSKI JAMES J Director | Purchase | +760,496 | +73406.95%761,532 | $0.47 | $361,164 | View SEC filing | |
| 2019-07-25 | CONTE LISA A CEO and President | Purchase | +37,500 | +100.00%37,500 | N/A | N/A | View SEC filing | |
| 2019-03-15 | Sagard Capital Partners, L.P. 10% Owner | Purchase | +33,149,556 | +100.00%33,149,556 | N/A | N/A | View SEC filing | |
| 2018-10-24 | Nantucket Investments Ltd 10% Owner | Sale | -307,596 | -10.78%2,545,504.668 | $3.17 | $1,090,470 | View SEC filing | |
| 2018-10-05 | Siegel Jonathan B. Director | Purchase | +25,000 | +166.67%40,000 | $0.60 | $15,000 | View SEC filing | |
| 2018-10-04 | Siegel Jonathan B. Director | Purchase | +268 | +1.82%15,000 | $1.19 | $319 | View SEC filing | |
| 2018-07-20 | Siegel Jonathan B. Director | Purchase | +5,000 | +51.38%14,732 | $1.10 | $5,476 | View SEC filing | |
| 2018-07-18 | CONTE LISA A CEO and President | Purchase | +1,500 | +25.00%7,500 | $1.11 | $1,669 | View SEC filing | |
| 2018-07-18 | Siegel Jonathan B. Director | Purchase | +9,732 | +336.02%9,732 | $1.32 | $12,846 | View SEC filing | |
| 2017-08-02 | BOCHNOWSKI JAMES J Director | Purchase | +100,000 | +14.33%797,935 | $0.50 | $50,000 | View SEC filing | |
| 2016-02-09 | BOCHNOWSKI JAMES J Director | Purchase | +160,000 | +48.84%487,576 | $2.50 | $400,000 | View SEC filing |
1-24 of 24